Diarrhoea in dogs is one of the most frequent reasons for veterinary consultations, acting as a common clinical sign across a wide spectrum of gastrointestinal disorders. While it is easy to view this symptom as a simple inconvenience, managing it requires a precise diagnostic approach. One of the most debated aspects of treatment is the use of antibiotics. Determining when these medications are necessary—and when they should be avoided—is critical to effective pet health management and preventing the rise of antibiotic resistance.
The Nature of Antibiotic-Responsive Diarrhoea (ARD)
Antibiotic-responsive diarrhoea (ARD), formerly known as small intestinal bacterial overgrowth (SIBO), is a specific clinical condition primarily affecting young dogs from large breeds. Interestingly, this condition is rarely observed in cats or small-breed dogs. The pathophysiology of ARD is not linked to the overgrowth of a single, isolated pathogen, but rather to a complex state of dysbiosis—an imbalance in the intestinal microflora.
The defining characteristic of ARD is that the patient shows a rapid, positive symptomatic response to specific antibiotic therapy. However, clinicians often observe that while dogs remain asymptomatic during the treatment window, they frequently relapse days, weeks, or even months after the medication is withdrawn. This cycle underscores the fact that antibiotics are a tool for management rather than a permanent cure for the underlying imbalance.
Choosing the Right Antibiotic Therapy
When a veterinarian determines that antibiotics are required, the selection is generally guided by availability, cost, and the potential impact on antibiotic resistance. Commonly used agents include metronidazole, oxytetracycline, and tylosin. Tylosin, in particular, has gained significant attention in veterinary literature, with some studies referring to the condition as “tylosin-responsive diarrhoea” (TRD) when it responds exclusively to this macrolide antibiotic.
Tylosin functions by inhibiting protein synthesis in sensitive microorganisms. It binds to the 50S ribosomal subunit, which effectively prevents the growth and replication of various gram-positive bacteria. Importantly, because tylosin is bacteriostatic rather than bactericidal, it does not “sterilize” the gut; instead, it slows bacterial proliferation, allowing the dog’s own immune system to stabilize the intestinal environment.
Recent research suggests another layer to tylosin’s efficacy: it appears to promote the growth of beneficial bacteria, such as Enterococcus spp. and lactic acid bacteria. These populations help regulate the broader microflora, reduce free radical damage in the intestinal tract, and support the generation of viral antibodies.
Clinical Management and Dosing Strategies
Tylosin is generally well-tolerated when administered orally. Nevertheless, as with any pharmaceutical intervention, owners should be aware of potential side effects, including transient loss of appetite, a temporary escalation of diarrhoea at the beginning of treatment, or false positives in certain liver chemistry panels (ALT and AST tests).
When treating chronic cases, the most successful outcomes often involve a multi-modal approach. Studies have demonstrated that combining tylosin with a high-quality dietary change—such as moving from a wet to a dry diet—provides superior results compared to using antibiotics alone.
Regarding dosage, evidence-based protocols indicate that lower doses can be highly effective, especially for managing recurrences. Clinical trials have shown that the majority of dogs that respond well to an initial therapeutic dose also maintain control of their symptoms with significantly lower daily doses, highlighting the importance of finding the minimum effective regimen to avoid unnecessary overuse.
Conclusion
Managing diarrhoea in dogs requires a thoughtful, science-based approach. While antibiotics like tylosin are potent tools for controlling ARD, they should only be used under the guidance of a veterinary professional who can distinguish between acute cases that resolve on their own and chronic cases requiring intervention. By combining targeted medical therapy with appropriate dietary adjustments, owners can effectively manage their dog’s digestive health and improve their long-term quality of life. Always consult your veterinarian to develop the safest and most effective treatment plan for your pet.
References
- Hall, E. J. (2011). Antibiotic-Responsive Diarrhoea in Small Animals. Veterinary Clinics of North America: Small Animal Practice, 41(2), 273–286.
- Westermarck, E., et al. (2005). Tylosin-responsive chronic diarrhoea in dogs. Journal of Veterinary Internal Medicine, 19(2), 177–186.
- Kilpinen, S., et al. (2015). Oral tylosin administration is associated with an increase of faecal enterococci and lactic acid bacteria in dogs with tylosin-responsive diarrhoea. The Veterinary Journal, 205(3), 369-374.
- Westermarck, E., Frias, R., & Skrzypczak, T. Effect of diet and tylosin on chronic diarrhoea in beagles. Journal of Veterinary Internal Medicine, 19(6), 822-827.
- Kilpinen, S., Spillmann, T., & Westermarck, E. (2014). Efficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhoea in dogs with tylosin-responsive diarrhoea. Acta Veterinaria Scandinavica, 56(1), 43.